A safer version of a potent antibiotic for serious infections that often causes hearing loss has been developed by scientists.
An estimated 20% to 60% of all patients treated with aminoglycoside antibiotics – including newborn babies – experience partial or complete deafness, which is irreversible.
Now researchers have produced a modified version of one of the drugs that works effectively in mice without causing hearing loss or kidney damage, another common side effect.